Therapeutic Effect of Omalizumab in Severe Asthma: A Real-World Study in Korea

PURPOSE: Omalizumab, an anti-immunoglobulin E (IgE) monoclonal antibody, has proved to be effective for the treatment of severe asthma. However, there is no direct evidence of effectiveness of omalizumab in Korean patients with severe asthma. We sought to evaluate the real-world effectiveness of oma...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji-Ho, Lee, Hyun Young, Jung, Chang-Gyu, Ban, Ga-Young, Shin, Yoo Seob, Ye, Young-Min, Nahm, Dong-Ho, Park, Hae-Sim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809760/
https://www.ncbi.nlm.nih.gov/pubmed/29411552
http://dx.doi.org/10.4168/aair.2018.10.2.121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809760/
https://www.ncbi.nlm.nih.gov/pubmed/29411552
http://dx.doi.org/10.4168/aair.2018.10.2.121

Ejemplares similares